The Legacy of the Nazi Lagers

On April 11, 1987, the Italian chemist and author Primo Levi was found dead in his apartment building in Turin. Reportedly depressed over worldwide violence, his deteriorating health, and a case of writer’s block, he apparently threw himself down the stairwell of his building. A survivor of Auschwitz, Levi had written a series of works, including The Periodic Table (Schochen Books, 1984), that intermingled stories of his captivity with metaphysical reflections (see THE SCIENTIST, May 18,

Written byPrimo Levi
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

BY PRIMO LEVI

The experiences that we survivors of the Nazi Lagers carry within us are extraneous to the new Western generation and become ever more extraneous as the years pass. For the young people of the 1950s and 1960s these were events connected with their fathers: they were spoken about in the family; memories of them still preserved the freshness of things seen. For the young people of the 1980s, they are matters associated with their grandfathers: distant, blurred, “historical.” These young people are besieged by today’s problems, different, urgent: the nuclear threat, unemployment, the depletion of resources, the demographic explosion, frenetically innovative technologies to which they must adjust. The world’s configuration is profoundly changed; Europe is no longer the center of the planet. The colonial empires have yielded to the pressure of the peoples of Asia and Africa thirsting for independence, having been dissolved not without tragedies and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies